Efmedaglutide alfa

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameEfmedaglutide alfa
Drug Alias Name依达格鲁肽αRecombinant human glucagon-like peptide-1 (hGLP-1) Fc fusion protein (Gannex)GLP1-hyFc (Gannex)重组人源胰高血糖素样肽-1（hGLP-1）Fc融合蛋白 (甘莱制药)Glucagon-like peptide-1 long-acting (Gannex) +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesI-Mab Bio-Tech (Tianjin) Co LtdCspc Baike (Shandong) Biopharmaceutical Co LtdI-Mab Biopharma Co Ltd +[4] 
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co LtdGannex Pharma Co Ltd
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A